Funding The Future: Accelerating The Long Walk To Innovation
Good ideas must be paired with good people
Executive Summary
In Vivo spoke with two company creators working in the biotech industry about their strategies for seeking new science and their funding philosophy when building the biotechs of tomorrow.
You may also be interested in...
Vaccitech Prepares For IPO, But AZ COVID-19 Vaccine Safety Fears Cloud Launch
The UK biotech aims to raise $100m, but will need to tackle safety concerns to secure a long-term future.
Fueled By Connections: Making It Happen In Rare Disease
Agios’s Sarah Gheuens talks to In Vivo about the responsibility of providing new therapies to rare disease populations, building trust with historically underserved communities, and why she loves working with small molecules.
Pushing Forward: Venture Capitalist Priorities To Accelerate European Biotech
Sharing his thoughts on the European funding landscape, the importance of software, and sustainable investments, INKEF Capital’s Thijs Cohen Tervaert talks to In Vivo about his investment priorities.